Astaxanthin prevents nephrotoxicity through Nrf2/HO-1 pathway
Canadian Journal of Physiology and Pharmacology · 2024
DOI: 10.1139/cjpp-2023-0015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Physiology and Pharmacology, 2024. Verfasst von Faezeh Lorestani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Biochemistry, Isfahan Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Acute Kidney Injury. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
Renal toxicity is one of the side effects of methotrexate (MTX). Therefore, this study explored the use of astaxanthin (AST), as a natural carotenoid, against MTX-induced nephrotoxicity emphasizing the changes in oxidative stress and the expression of nuclear factor erythroid 2-related factor 2/heme oxygenase 1 ( Nrf2/HO-1). During the 10 days of the experiment, male Wistar rats in different groups received MTX (10 mg/kg) on days 6, 8, and 10 and three doses of AST (25, 50, and 75 mg/kg) during the entire course. Renal failure caused by MTX was observed in significant histopathological changes and a significant increase in serum levels of creatinine, urea, and uric acid ( p < 0.05). Oxidative change induced by MTX injection was also observed by remarkably increasing the tissue level of malondialdehyde (MDA) and decreasing the activity of superoxide dismutase (SOD) and catalase ( p < 0.001). AST decreases the adverse effects of MTX by upregulating the expression of Nrf2/HO-1 genes ( p < 0.01) and decreasing the tissue level of MDA ( p < 0.01). Also, AST significantly reduced the amount of creatinine, urea, and uric acid in the serum and improved the activity of SOD and catalase in the kidney tissue ( p < 0.05). Thus, AST may protect the kidney against oxidative stress caused by MTX.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Biochemistry, Isfahan Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
- Department of Pathobiology, Faculty of Veterinary Medicine, Razi University, Kermanshah, Iran.
ORCID-Profile: Faezeh Lorestani, Ahmad Movahedian, Adel Mohammadalipour, Mohammad Hashemnia, Mohammad Hossein Aarabi
Zitieren
APA
Lorestani, F., Movahedian, A., Mohammadalipour, A., Hashemnia, M., & Aarabi, M. H. (2024). Astaxanthin prevents nephrotoxicity through Nrf2/HO-1 pathway. Canadian Journal of Physiology and Pharmacology. https://doi.org/10.1139/cjpp-2023-0015
Vancouver
Lorestani F, Movahedian A, Mohammadalipour A, Hashemnia M, Aarabi MH. Astaxanthin prevents nephrotoxicity through Nrf2/HO-1 pathway. Canadian Journal of Physiology and Pharmacology. 2024. doi:10.1139/cjpp-2023-0015
BibTeX
@article{Lorestani2024,
author = {Lorestani, Faezeh and Movahedian, Ahmad and Mohammadalipour, Adel and Hashemnia, Mohammad and Aarabi, Mohammad Hossein},
title = {Astaxanthin prevents nephrotoxicity through Nrf2/HO-1 pathway},
journal = {Canadian Journal of Physiology and Pharmacology},
year = {2024},
doi = {10.1139/cjpp-2023-0015}
}
EUVIMED